Implication of ADAM-8, -9, -10, -12, -15, -17, and ADAMTS-1 in Implantational Remodeling of a Mouse Uterus by Kim, Jiyoung et al.
Yonsei Medical Journal
Vol. 47, No. 4, pp. 558 - 567, 2006
Yonsei Med J Vol. 47, No. 4, 2006
In the present study, whether the ADAM-8, -9, -10, -12,
-15, -17, and ADAMTS-1 proteins might play a role in mouse
uterus during periimplantation period was investigated. Immu-
noblotting analyses demonstrated that all ADAM proteins
consistently appeared throughout days 1 to 8 of pregnancy but
with a variation depending on the species of ADAM gene, the
progression of pregnancy, and the site of the uterus. Immu-
nohistochemical analyses indicated that ADAM proteins were
localized in the luminal or glandular epithelial layers with a
varying intensity depending on the species of ADAM and the
progression of pregnancy. Particularly ADAM-8, -12, and -15,
were predominantly located in the implantation site of the
uterine tissues, whereas little or no protein was localized in
the interimplantation site. Based upon these observations, it is
suggested that the ADAMs might play an important role in
the remodeling of the mouse uterus during the periimplantation
period.
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INTRODUCTION
ADAMs (a disintegrin and metalloprotease) is a
unique family of protein members consisting of a
prodomain, metalloprotease, disintegrin-like and
cysteine-rich domains, and, in most cases, epider-
mal growth factor-like, transmembrane, and
cytoplasmic domains. Their disintegrin and cys-
teine-rich domains can interact with integrins.
Disintegrin domains of ADAM-9/MDC-9/mel-
trin- can function as an adhesion molecule by γ
interacting with an v 5 integrin. α β
1 The disintegrin
and cysteine-rich domains of ADAM-12/meltrin-α
represent two functional ligands for an 7 1 inte α β -
grin, and adhesion to each of these two ligands
via the 7 1 integrin triggers different cellular α β
responses.
2 Recombinant ADAMs-12 and ADAM-
15/metargidin/MDC15 disintegrin domains speci-
fically interact with integrin 9 1 in an RGD-in α β -
dependent manner.
3 Due to these properties,
ADAMs play many important roles in cell-cell
and cell-matrix interactions. ADAMTS (a disinteg-
rin and metalloprotease with thrombospondin
motifs) is a relatively new family of ADAM-re-
lated proteins. They differ from the other ADAMs
by a unique character - a thrombospondin type
1-repeat motif lying between the disintegrin and
the cysteine-rich domains. Of the currently known
30 members, ADAMTS-1/METH-1 is the proto-
type and plays an important role in normal
growth, fertility, and organogenesis.
4 ADAMTS-
5/aggrecanase-2 and ADAMTS-6 are exclusively
expressed in the placenta suggesting their possible
role during implantation in mice.
5 In light of these
findings and others, a vast amount of studies
attribute the proteolytic and/or cell adhesion
activities of ADAM and ADAMTS proteins to the
remodeling of various tissues.
Mammalian uterus is a dynamic organ that
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undergoes a cyclic degradation and renewal
during the reproductive cycle and a drastic re-
modeling during pregnancy. At the beginning of
implantation, endometrial fibroblasts surrounding
the embryo transform into an epithelioid cell type,
in a reaction called decidualization, which is de-
pendent on the priming by ovarian steroid hor-
mones. Decidualization in murine endometrium
involves cell growth and a severe reduction of the
extracellular spaces accompanying modifications
of many extracellular matrix (ECM) components.
In mice, progressive loss of laminin and type IV
collagen in the uterine luminal epithelial basement
membrane occurs in a consistent spatiotemporal
pattern following the onset of blastocyst implan-
tation, which is closely correlated with the area
occupied by decidualized endometrial stroma and
occurs in areas not yet in contact with trophoblast
cells.
6 High levels of collagen type VI protein are
present in the endometrium and myometrium of
mouse uterus up to day 4.5 of pregnancy. After
implantation, reduction in collagen type VI pro-
tein within the decidualizing endometrium cor-
relates with the reduced levels of alpha 1, 2, and
3 chain mRNAs. During decidualization of the
endometrium, differences in the nature and the
amount of proteoglycans are observed suggesting
the changes of collagen fibril thickness observed.
7
The profile of small leucine-rich proteoglycans in
the uterine ECM alters the differentiation of endo-
metrial stromal cells.
8 During the periimplantation
period, perlecan in the extracellular spaces of the
endometrial stroma is lost. Beginning soon before
implantation, syndecan-4 increases in the fibro-
blasts of the subepithelial stroma, and after im-
plantation, syndecan-4 is pronounced in pre-
decidual and mature decidual cells.
8 These obser-
vations indicate that the mouse uterus undergoes
a considerable degree of remodeling during im-
plantation.
Among the factors involved in the rearrange-
ment of ECM components accompanying de-
cidualization, matrix metalloproteinases (MMPs)
and tissue inhibitors of matrix metalloproteinase
(TIMPs) have been studied extensively and are
known to play important roles in the uteri of
many mammals.
9 In mice, early pregnancy is asso-
ciated with the expression of mRNA and positive
immunoreactivity for multiple MMPs, including
MMP-2, -3, -7, -9, -11, -13, and membrane type-
MMP-1. Recently we observed that cycling mouse
uteri exhibited differential mRNA expression of
ADAM genes identical to those in the present
study depending on the oestrous stage suggesting
their roles in remodeling during the cycle.
10
In the present study, immunoblotting and im-
munohistochemistry techniques were used to
determine whether ADAM-8, -9, -10, -12, -15, -17,
and ADAMTS-1 might play a role in uterine
remodeling during implantation in mice.
MATERIALS AND METHODS
Animals
ICR mice were supplied from Daehan Biolink
(Daejeon, Korea). Animals were kept under con-
ditions that followed the institutional guidelines
of Seoul Women's University for the care and use
of experimental animals, under controlled lighting
(12 h light-dark cycle). Sexually mature (6-8 week
old) female mice were used. Females were mated
with fertile males of the same strain and checked
for vaginal plugs on the following morning. The
day of vaginal plug formation was regarded as
day 1 of pregnancy. Whole uteri were collected
from pregnant mice on days 1-5. From days 6 to
8 of pregnancy, when implantation and interim-
plantation sites were visualized, uterine tissues of
each site were separately collected.
Chemicals
Acrylamide, bisacrylamide, and N,N,N',N'-
tetramethylethylenediamine were purchased from
Bio-Rad (Hercules, CA, USA). Rabbit polyclonal
antibodies against mouse ADAM-9, -10, -12, -15,
and -17 were purchased from Chemicon (Temecula,
CA, USA). Goat polyclonal antibodies against
mouse ADAM-8, -10, -12, -15, and ADAMTS-1
were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Goat polyclonal antibody
against mouse ADAM-9 was purchased from R & D
Systems (Minneapolis, MN, USA). All other
chemicals were supplied by Sigma (St. Louis, MO,
USA) unless specified elsewhere.Jiyoung Kim, et al.
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Immunoblotting
Mouse uterine tissue was homogenized in a
lysis buffer (0.125 M Tris-HCl, pH 6.8) containing
1 mM ethylenediaminetetraacetic acid (EDTA), 1
mM phenylmethylsulfonyl fluoride, and 1 g/ L μ μ
soybean trypsin inhibitor. Insoluble materials
were precipitated by centrifugation at 12,000 × g
for 15 min at 4 . The supernatants were regarded
as total cell lysates. The protein concentration of
each sample was determined using a bicinchoni-
nic acid protein assay kit (Pierce, Rockford, IL,
USA). Samples were diluted with equal volumes
of a reducing sample buffer (0.125 M Tris-HCl, pH
6.8, 4% sodium dodecyl sulfate (SDS), 10% mer-
captoethanol, 20% glycerol, and 0.004% bromo-
phenol blue), and then boiled for 3 min at 95 .
Fifty micrograms of protein was loaded into each
lane. Proteins were separated by SDS-polyacryl-
amide gel electrophoresis on an 8% acrylamide gel
in parallel with a prestained protein molecular
marker. Subsequently, gels were soaked in a
transfer buffer composed of 25 mM Tris (pH 8.4),
192 mM glycine, and 10% methanol for 15-30 min.
To hydrate the polyvinylidene difluoride (PVDF)
membranes (Immobilon-P, Millipore, Bedford,
MA, USA), they were soaked in absolute meth-
anol for 15 s, soaked in distilled water for 2 min,
and then equilibrated in transfer buffer for 5 min.
Proteins on the gel were electrotransferred onto a
PVDF membrane for 60 min at 4 and 100 V. To
saturate non-specific binding sites after transfer,
membranes were incubated at 37 for 1 h in a
washing buffer containing 0.8% NaCl, 0.02% KCl,
0.144% Na2HPO4 2H2O, 0.02% KH2PO4, 0.2%
Tween 20, 10 mM sodium azide, and 5% bovine
serum albumin (BSA). Membranes were then in-
cubated for 1 h in washing buffer containing 1%
normal goat serum and 1 g/mL rabbit polyclonal μ
antibody against mouse ADAM-9, -10, -12, -15, or
-17. Following several washes with the washing
buffer containing 0.1% BSA, membranes were
incubated for 2 h in washing buffer containing
1:100 diluted gold-labeled goat anti-rabbit IgG.
After reaction, the signal was visualized using an
IntenSE BL kit (Amersham, Buckinghamshire,
England) according to the manufacturer's instruc-
tions. Immunoblotting results were confirmed by
three independent experiments. For ADAM-8 and
ADAMTS-1, membranes were incubated for 1 h in
washing buffer containing 1% normal donkey
serum and 1 g/mL goat polyclonal antibody μ
against mouse ADAM-8 or ADAMTS-1. They
were then incubated for 1 h in washing buffer
containing 2 g/mL biotinylated donkey antibody μ
against goat IgG. After several washes with the
washing buffer containing 0.1% BSA, membranes
were incubated for 2 h in washing buffer con-
taining 1:100 diluted streptavidin-conjugated 10-
nm gold particles. Signals were detected using the
same IntenSE BL kit.
Immunohistochemistry
Mouse uterine tissue was fixed with 4% para-
formaldehyde in PBS at 4 , processed into paraf-
fin, and then sectioned at 4 m. The sections on μ
silane coating slides (Corning, NY, USA) were
deparaffinized using xylene and rehydrated with
ethyl alcohol and distilled water. To quench endo-
genous peroxidase, the sections were incubated in
3% hydrogen peroxide for 10 min at room tem-
perature. Following several washes with Tris-
buffered saline (TBS: pH 7.4, 5 mM Tris, 0.15 M
NaCl, and 0.05% Tween 20), the sections were
soaked in 10 mM citrate buffer solution (pH 6.0)
and heated with a microwave twice for 8 min
each. After cooling the sections for 20 min at room
temperature, they were incubated with 1:25 di-
luted goat polyclonal antibody against mouse
ADAM-8, -10, or ADAMTS-1 overnight at 4 ,
with goat polyclonal antibody against mouse
ADAM-9, -12 (diluted to 1:50), or -15 (diluted to
1:100) for 1 h at room temperature. After gentle
agitation in TBS three times for 5 min each, the
sections were incubated with 1:300 diluted bio-
tinylated anti-goat IgG (Dako, Carpinteria, CA,
USA) for 30 min at room temperature. After being
rinsed, the sections were incubated with strepta-
vidin-biotin peroxidase complex (Dako) for 10
min. For ADAM-17, the sections were incubated
with 1:100 diluted rabbit polyclonal antibody
against mouse ADAM-17 for 1 h, and then washed
several times with TBS. The sections were in-
cubated with EnVison
TM containing horseradish
peroxidase anti-rabbit IgG (Dako) for 40 min at
room temperature. Immunoreactivity for ADAM
proteins was visualized utilizing 3,3'-diaminoben-ADAMs in Implantation
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zidine tetrahydrochloride and counterstained with
Mayer's haematoxylin. Finally the sections were
photographed under bright-field illumination
using a microscope (LSM410, Carl Zeiss, Ober-
kochen, Germany).
RESULTS
Protein expression of ADAM-8
In mouse uterine extracts, proteins of ADAM-8
were detectable as two bands of 62 kDa and a
smaller 58 kDa. During days 1-5 of pregnancy, the
62-kDa protein was observed with strong intensity
on day 1 and weak intensity was observed on day
3. Intensity of the 58-kDa protein was strong on
days 1-3 but decreased thereafter. During days 6-8
of pregnancy, the 62-kDa intensity was constantly
strong at interimplantation sites but it decreased
and was almost undetectable on day 8 of pre-
gnancy. Staining intensity of the 58-kDa protein
increased at both implantation and interimplan-
tation sites as pregnancy progressed (Fig. 1A).
On day 1, intense staining of ADAM-8 protein
was observed in both the luminal and glandular
epithelia, but the intensity weakened on day 3. By
day 5, distinct signal was uniformly distributed in
the luminal epithelium. On day 6, intense staining
was observed in the luminal epithelium but not
in the glandular epithelium of the implantation
site. No discernable staining was observed at the
interimplantation site.
Protein expression of ADAM-9
Protein expression of 84-kDa ADAM-9 grad-
ually increased from day 1 to day 5 and strong
expression was observed on day 5. On days 6-8,
intense staining was observed at the implantation
site whereas little or no signal was seen at the
interimplantation site (Fig. 2A).
ADAM-9 protein on day 3 was mostly located
in the glandular epithelium. Only weak staining
was seen in the luminal epithelium. On day 5, a
high level of ADAM-9 protein was detected in
both the luminal epithelium and the glandular
epithelium. On days 6-8, intense staining was seen
in the same area of the implantation site but little
or no staining was observed at interimplantation
site (Fig. 2B).
Protein expression of ADAM-10
Low intensity of the 85-kDa ADAM-10 protein
was observed in the tissue extract of day 1 uterus.
On days 2-5, ADAM-10 protein signal was dis-
cernable and the intensity remained constant.
Tissues on days 6-7 exhibited a similar intensity
of staining. However, tissue from day 8 showed
stronger staining at the implantation site com-
pared to the interimplantation site (Fig. 3A).
Discernable staining of ADAM-10 protein was
seen in both the luminal and glandular epithelia
of day 3 uterus. On day 5, the intensity markedly
increased, particularly in the luminal epithelium.
On day 6, strong staining was observed in both
epithelia of the implantation site, whereas positive
staining was seen only in the luminal epithelium
of the interimplantation site (Fig. 3B).
Protein expression of ADAM-12
The staining intensity of the 120-kDa ADAM-12
protein on day 1 was weak but gradually in-
creased, reaching a peak on day 5. During days
6-8, the intensity of ADAM-12 at the implantation
site became strong whereas that at the interim-
plantation site became very faint such that on day
8 (Fig. 4A).
Localization of ADAM-12 protein was not seen
in the uterus at day 1. On day 3, localization was
observed in the luminal epithelium. By day 5, the
staining intensity in both luminal and glandular
epithelia became more pronounced. On day 6,
very intense staining was observed in both epi-
thelia of the implantation site, while little staining
was observed in the interimplantation site (Fig.
4B).
Protein expression of ADAM-15
On day 1, a low ADAM-15 protein signal was
observed on immunoblot analysis. On day 2 and
afterwards, the presence of ADAM-15 protein was
detected as two bands, 100 kDa and 90 kDa, and
the intensity of the 100-kDa band was always
stronger than that of the 90-kDa band. As pre-Jiyoung Kim, et al.
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gnancy continued up to day 5, the staining in-
tensity of both proteins markedly increased. On
days 6-8, the staining intensity of both proteins at
the implantation site progressively increased
while that of interimplantation site, on the con-
trary, gradually decreased. On day 8, strong stain-
ing of both proteins was observed at the implan-
tation site while weak staining was observed at
the implantation site (Fig. 5A).
No immunostaining of ADAM-15 protein was
observed on day 1. However, positive staining
was detected on day 3, particularly in the glandu-
Fig. 4. Spatial and temporal expression of ADAM-12 in
mouse uterus on days 1-8 of pregnancy. A, immunoblot
results of uterine tissue extracts. Numerical numbers indi-
cate the day of pregnancy; n and m indicate the type of
uterine tissues obtained from implantation (m) or inter-
implantation (n) sites. B, immunolocalization of ADAM-
12 in mouse uterus during early pregnancy. Uterine cross
sections are shown for pregnant day 1 (A), pregnant day
3 (B), pregnant day 5 (C), interimplantation site (D), and
implantation site (E) on day 6 of pregnancy. le, luminal
epithelium; ge, glandular epithelium. × 100.
Fig. 3. Spatial and temporal expression of ADAM-10 in
mouse uterus on days 1-8 of pregnancy. A, immunoblot
results of uterine tissue extracts. Numerical numbers
indicate the day of pregnancy; n and m indicate the type
of uterine tissues obtained from implantation (m) or interi-
mplantation (n) sites. B, immunolocalization of ADAM-10
in mouse uterus during early pregnancy. Uterine cross
sections are shown for pregnant day 1 (A), pregnant day
3 (B), interimplantation site (C), and implantation site (D)
on day 6 of pregnancy. le, luminal epithelium; ge, glandu-
lar epithelium. × 100.
Fig. 2. Spatial and temporal expression of ADAM-9 in
mouse uterus on days 1-8 of pregnancy. A, immunoblot
results of uterine tissue extracts. Numerical numbers
indicate the day of pregnancy; n and m indicate the type
of uterine tissues obtained from implantation (m) or inter-
implantation (n) sites. B, immunolocalization of ADAM-9
in mouse uterus during early pregnancy. Uterine cross
sections are shown for pregnant day 3 (A), pregnant day
5 (B), interimplantation site (C), and implantation site (D)
on day 6 of pregnancy. le, luminal epithelium; ge, glandu-
lar epithelium. × 100.
Fig. 1. Spatial and temporal expression of ADAM-8 in
mouse uterus on days 1-8 of pregnancy. A, immunoblot
results of uterine tissue extracts. Numerical numbers
indicate the day of pregnancy; n and m indicate the type
of uterine tissues obtained from implantation (m) or inte-
rimplantation (n) sites. B, immunolocalization of ADAM-
8 in mouse uterus during early pregnancy. Uterine cross
sections are shown for pregnant day 1 (A), pregnant day
3 (B), pregnant day 5 (C), interimplantation site (D), and
implantation site (E) on day 6 of pregnancy. le, luminal
epithelium; ge, glandular epithelium. × 100.
A
B
A
B
A
B
A
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lar epithelium. On day 5, very strong staining
was observed in both sites. By day 6, strong
staining was seen in the epithelia of the implan-
tation site only. No distinct staining was observed
at the interimplantation site (Fig. 5B).
Protein expression of ADAM-17
Immunoblot analyses showed the appearance of
ADAM-17 protein as two reactive bands of 115
kDa and 100 kDa. Both protein levels were noted
strongly on days 2-4 of pregnancy but the inten-
sity of the 115 kDa band was stronger than that
of the 100 kDa. On day 5, both proteins were
weakly stained. On day 6, a strong intensity of
100-kDa protein was noted at both implantation
and interimplantation sites. By day 7, a strong
115-kDa and weak 100-kDa bands were observed
at the interimplantation site, but a weak 115 kDa-
and strong 100-kDa bands at the implantation site
were demonstrated. On day 8, a strong 115-kDa
and weak 100-kDa band was observed in the
interimplantation site but both proteins were
intensely stained at the implantation site (Fig. 6A).
On day 1 of pregnancy, little staining of ADAM-
17 protein was observed (Fig. 6B). On days 4 and
5, a relatively high level of signal was found in
both epithelia. On day 6, the luminal and glan-
dular epithelia of both interimplantation and
implantation sites exhibited strong staining.
Protein expression of ADAMTS-1
Weak immunostaining of the 88-kDa ADAMTS-
Fig. 7. Spatial and temporal expression of ADAM-TS1 in
mouse uterus on days 1-8 of pregnancy. A, immunoblot
results of uterine tissue extracts. Numerical numbers
indicate the day of pregnancy; n and m indicate the type
of uterine tissues obtained from implantation (m) or inter-
implantation (n) sites. B, immunolocalization of ADAM-
TS1 in mouse uterus during early pregnancy. Uterine
cross sections are shown for pregnant day 1 (A), pregnant
day 4 (B), pregnant day 5 (C), interimplantation site (D),
and implantation site (E) on day 6 of pregnancy. le, lumi-
nal epithelium; ge, glandular epithelium. × 100.
Fig. 6. Spatial and temporal expression of ADAM-17 in
mouse uterus on days 1-8 of pregnancy. A, immunoblot
results of uterine tissue extracts. Numerical numbers
indicate the day of pregnancy; n and m indicate the type
of uterine tissues obtained from implantation (m) or inter-
implantation (n) sites. B, immunolocalization of ADAM-
17 in mouse uterus during early pregnancy. Uterine cross
sections are shown for pregnant day 1 (A), pregnant day
4 (B), pregnant day 5 (C), interimplantation site (D), and
implantation site (E) on day 6 of pregnancy. le, luminal
epithelium; ge, glandular epithelium. × 100.
Fig. 5. Spatial and temporal expression of ADAM-15 in
mouse uterus on days 1-8 of pregnancy. A, immunoblot
results of uterine tissue extracts. Numerical numbers
indicate the day of pregnancy; n and m indicate the type
of uterine tissues obtained from implantation (m) or inter-
implantation (n) sites. B, immunolocalization of ADAM-15
in mouse uterus during early pregnancy. Uterine cross
sections are shown for pregnant day 1 (A), pregnant day
3 (B), pregnant day 5 (C), interimplantation site (D), and
implantation site (E) on day 6 of pregnancy. le, luminal
epithelium; ge, glandular epithelium. × 100.
A
B
A
B
A
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1 protein was seen on day 1. The staining inten-
sity of the protein remarkably increased until day
5. During days 6-8, the staining intensity at the
implantation site was greater than that of the
interimplantation site (Fig. 7A).
Localization of ADAMTS-1 protein was not
discernable on day 1. On day 4, distinct staining
was observed in the glandular epithelium. Weak
staining was seen in the luminal epithelium. On
day 5, intense staining was observed in both
epithelia. By day 6, weak signal was observed in
both epithelia at the interimplantation site,
whereas intense staining was observed in both
epithelia at the implantation site (Fig. 7B).
DISCUSSION
The present study demonstrates that the
ADAM-8, -9, -10, -12, -15, -17, and ADAMTS-1
proteins might play important roles in the remo-
deling of the mouse uterus during the periim-
plantation period using immunoblotting and
immunohistochemistry techniques.
Increasing evidence has suggested the impor-
tance of the ADAM family of proteins in various
tissues. ADAM-8 is involved in neurite outgrowth
and the suppression of neuronal death, the up-
regulation of IgE production, and the induction of
inflammatory cytokines in B cell lines.
11 While its
role in these cells is mediated by proteolytic
activity, it also displays adhesive activity. The
importance of adhesive activity has been shown in
the neurodegeneration observed in wobbler mu-
tant mice
12 and in later stages of osteoclast differ-
entiation from monocytic precursors.
13 In mouse
uterus, ADAM-8 protein exhibited differential
expression from day 1 throughout day 5 of preg-
nancy. After the onset of implantation, ADAM-8
expression was even spatially restricted to the
epithelial layers of the implantation site. These
spatiotemporal expressions imply that ADAM-8
expression might be related to the initiation and
maintenance of implantation. Western blot an-
alyses of ADAM-8 protein showed two proteins,
62-kDa and 58-kDa forms. Since the 62-kDa form
is known to generate the 58-kDa form by removal
of a carbohydrate,
14 the 58-kDa form observed in
mouse uterus is likely to be a further processed
form of the 62-kDa. In the implantation site, the
62-kDa protein gradually diminished whereas the
58-kDa protein greatly increased as pregnancy
progressed, implying that the latter form might be
related to the implantation process. Both the
62-kDa and 58-kDa forms, however, have been
shown to lack metalloprotease activity but to
function via adhesive activity.
15 Taken together,
these observations suggest that ADAM-8 might
play a role in remodeling of the mouse uterus
before and after implantation, and act via an
adhesive interaction with apposed epithelial cells,
stromal cells, and/or embryos.
Immunohistochemical signaling of ADAM-12
protein in mouse uterus remarkably increased
from the beginning of pregnancy, but the locali-
zation was spatially restricted to the implantation
site. Western blot results demonstrated ADAM-12
proteins as a ~120-kDa proform, which lacks pro-
teolytic activity and a ~90-kDa mature, processed-
form, which lacks a prodomain but possesses
proteolytic activity. In fibroblasts and myoblasts,
the ~120-kDa is the predominant form with minor
expression of the ~90-kDa form.
15 However, the
amount of the proteins in these cell lysates is too
small to detect, unless they are concentrated by
immunoprecipitation or affinity chromatography.
15 In contrast, pregnant mouse uterine tissues
synthesized a vast amount of the ~120-kDa form,
as revealed by the fact that the protein was
visualized without concentration. The ~90-kDa
was not detected probably because of a minute
quantity. For the proliferation of myoblasts and
reserve cells, and the differentiation of early adi-
pocytes,
16 ADAM-12 acts via its cell-cell and/ or
cell-matrix adhesion activity. In cardiomyocytes,
COS-1 cells, osteoblasts and other cells,
17 ADAM-
12 exhibits proteolytic activity by releasing HB-
EGF, insulin-like growth factor-binding protein
(IGFBP)-3, or IGFBP-5. Participation of ADAM-12
in proliferation and differentiation of uterine tis-
sues from the beginning of pregnancy is thus sug-
gested to be due to one or both of these activities.
ADAM-15 protein is initially synthesized as a
~110-kDa protein but is soon transformed into the
90-kDa form by removal of the prodomain.
18 In
mouse tissues such as heart, lung, muscle, brain,
spleen, and testis, the amount of ADAM-15 pro-
tein is so small that only the 90-kDa form hasADAMs in Implantation
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been found even after concentration of the tissue
lysates.
18 In the present study, however, both the
100-kDa and 90-kDa proteins were easily detected
in lysates of uterine tissues that were prepared
without concentration, indicating that mouse
uterus actively synthesizes and processes ADAM-
15 proteins. While the amount of 90-kDa protein
preferentially increased during days 1-5, both the
100-kDa and 90-kDa proteins increased after the
onset of implantation and, particularly, at the
implantation site. During early pregnancy in mice,
progressive loss of laminin and type IV collagen
in the uterine luminal epithelial basement mem-
brane occurs in the area occupied by decidualized
endometrial stroma and in the area not yet in
contact with trophoblast cells.
6 Since ADAM-15
can cleave type IV collagen and gelatin,
19 its role
in mouse uterus appears to be the reconstruction
of ECM components during implantation. ADAM-
15 has also been implicated in cartilage destruc-
tion found in inflammatory joint disease, in the
restructuring of the mesangial matrix in mesan-
giocapillary glomerulonephritis, and in endothe-
lial functions.
19 The potential role of ADAM-15 in
these events appears to be mediated via its spe-
cific interaction with integrin v 3 in an RGD- α β
dependent manner, with integrin 9 1 in an RGD- α β
independent manner,
3 or ectodomain sheddase
activity.
11 Revealing the action mode of ADAM-15
will give an insight about its specific role in the
mouse uterus during the periimplantation period.
In many mammals, the apical surface of the
uterine epithelium is covered by a mucin glyco-
calyx. In rabbits, the presence of blastocysts in the
uterine lumen resulted in a localized reduction of
Muc1 at the implantation site of the luminal
epithelium; higher expression of ADAM-9 was
shown to correlate with the implantation site by
an in situ hybridization study.
20 Thus ADAM-9
was suggested to play a role as a MUC1 sheddase
during the implantation window for rabbit
embryos. Human uterine epithelial cells cultured
in vitro also exhibited a local loss of MUC1 at the
site of blastocyst adhesion. In the receptive phase
of human endometrium, luminal and glandular
uterine epithelial cells was the predominant site of
MUC1 localization and ADAM-17 protein has
been localized to this area.
21 These findings sug-
gested that in humans, ADAM-17 appears to be
responsible for the shedding of MUC1.
21 In mice,
MUC-1 expression was higher in the proestrous
and oestrous stages, and its protein declined to
barely detectable levels by day 4 of pregnancy, i.e.
before the time of blastocyst attachment.
22 In
earlier studies conducted with the same experi-
ment system, genes of ADAM-8, -12, and -15
began to increase in expression from the begin-
ning of pregnancy or on day 3 until day 5, which
is around the time of implantation.
10 Thus one or
more of these ADAMs can be candidates for
mouse MUC1 sheddase. In the present study, we
monitored the expression of ADAM proteins.
Unlike ADAM-9 and -12, ADAM-8, -10, -15, and
-17 did not show any significant change in the
level of protein expression during this period.
However, after initiation of implantation, differen-
tial expression was observed such that strong
expression was seen on day 8 at the implantation
site and significantly lower expression occurred at
the interimplantation site. Therefore these ADAMs
seem to be involved in uterine remodeling after
the initiation of implantation rather than before
implantation.
ADAM-9 has been shown to play an either
adhesive or proteolytic role. The disintegrin
domain of ADAM-9 can function as an adhesion
molecule by interacting with an v 5 integrin in α β
an RGD-independent manner or an 6 1 integrin. α β
1
Its metalloprotease domain has an alpha-secretase-
like activity that cleaves amyloid precursor pro-
tein, acts as an insulin-like growth factor binding
protein-5 protease in human osteoblasts, or de-
grades gelatin, -casein, and fibronectin. β
23 It would
be interesting to determine which type of ADAM-
9 activity is involved in the remodeling of uterine
tissues. Many studies have attributed the role of
ADAM-10 to an ectodomain sheddase releasing a
soluble fragment from Delta1 ligand, to an am-
yloid precursor protein cleaving enzyme 1 shed-
dase, to a vesicle-based protease targeting L1, or
to a sheddase of EGF and betacellulin.
24 Con-
sidering that there is no known adhesive activity
of ADAM-10, ADAM-10 is believed to function in
the mouse uterus via its proteolytic activity.
ADAM-17 is produced as an inactive zymogen of
100-115 kDa in size, which is subsequently proteo-
lytically processed to the catalytically active form
of 85-100 kDa size.
25 Thus, the 110 kDa and 100Jiyoung Kim, et al.
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kDa bands observed in the mouse uterus repre-
sent an inactive proform and an active processed
form, respectively. Since ADAM-17 is well known
to act as a sheddase for various cell signaling
molecules and their receptors,
26 uterine ADAM-17
is suggested to function via its proteolytic activity.
Unlike other ADAMs in the present study,
ADAMTS-1 does not contain a transmembrane
domain and after synthesis, it is secreted into
ECM. It binds to the heparin-binding domain of
vascular endothelial cell growth factor, inhibiting
endothelial cell proliferation.
27 As a metallopro-
tease, it can cleave versican or aggrecan, resulting
in impaired ovulation.
28 In mouse uterus, versican
has been reported to localize in the decidualized
region.
29 Since ADAMTS-1 depends on a proges-
terone receptor in response to luteinizing hor-
mone in the periovulatory follicles of mice,
30 it
seems to play a role in the uterus, a major target
of progesterone, by acting on ECM molecules
and/or growth factors.
While our studies suggest that all of these
ADAM genes might play a role in the tissue
remodeling of mouse uterus during the periim-
plantation period, birth and/or normal develop-
ment of knockout mice of ADAM-8,
31 -9,
32 -12,
33
-15,
34 -17,
34 or ADAMTS-1
28 have shown that these
genes do not play a critical role in uterine
function. One possible explanation for the discrep-
ancy is that other related genes could overcome
the lack of one gene's function. Many studies have
suggested the compensation for loss of function in
knockout mice. For example, desmoglein-1 could
compensate for the function of desmoglein-3 I
telogen in hair.
35 Epidermal fatty acid binding
protein (E-FABP)-deficient mice appeared normal
by the compensation of heart-type FABP for a E-
FABP deficiency.
36 A three- to seven-fold increase
in nidogen-2 was observed in the heart and
muscle of mice with nidogen-1 deficiency.
37 In
closer relation to ADAMs, expressions of MMP-3/
stromelysin-1 and MMP-10/stromelysin-2 were
dramatically upregulated in MMP-7/matrilysin-
deficient mice, while expressions of MMP-7 and
MMP-10 were also upregulated in MMP-3-defi-
cient mice.
38 In these contexts, normality reported
in knockout mice of the ADAM-9, -12, -15, -17,
and ADAMTS-1 genes could be due to com-
pensation by other ADAM genes or related genes.
Based on these results, we suggest that ADAM-
8, -9, -10, -12, -15, -17, and ADAMTS-1 might play
roles in uterus remodeling during the periim-
plantation period. However, the normality of
ADAM gene knockout mice, except for ADAM-10,
indicates that they might be not critical for uterine
function. Further studies will clarify whether the
compensation by other genes might indeed take
place in ADAM-deficient mice.
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